APP and Alzheimer disease: Tropisetron, a potent α7 nAChR agonist and 5-HT3 receptor antagonist, also bound to the ectodomain of amyloid precursor protein. Furthermore, tropisetron promoted greater improvements in memory current AD therapeutic drugs AD.